Satsuma Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch STSA and buy or sell other stocks, ETFs, and their options commission-free!

About STSA

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. 

CEO
Ryoichi Nagata, MD, PhD
CEORyoichi Nagata, MD, PhD
Employees
—
Employees—
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
2016
Founded2016
Employees
—
Employees—

STSA Key Statistics

Market cap
36.47M
Market cap36.47M
Price-Earnings ratio
-0.55
Price-Earnings ratio-0.55
Dividend yield
—
Dividend yield—
Average volume
412.49K
Average volume412.49K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$8.08
52 Week high$8.08
52 Week low
$0.59
52 Week low$0.59

People also own

Based on the portfolios of people who own STSA. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Nikola
Cenntro Electric Group Li…
Ideanomics
NIO
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.